Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
SeaStar Medical announced a 69% increase in first quarter revenue driven by expanding its QUELIMMUNE therapy customer base to 17 top children's hospitals. The company is progressing enrollment in its NEUTRALIZE-AKI pivotal clinical trial for adult Acute Kidney Injury (AKI) patients and is preparing a modular post-marketing application to accelerate…
FormFactor, Inc. has been ranked the global number one supplier in both Test Subsystems and Focused Suppliers of Chip Making Equipment in the TechInsights 2026 Customer Satisfaction Survey, marking its thirteenth consecutive year of recognition in Test Subsystems. The company's leadership reflects its technology innovation and strong customer trust…
Zentalis Pharmaceuticals, a clinical-stage oncology company focusing on developing a first-in-class WEE1 inhibitor called azenosertib for ovarian cancer and other tumor types, announced its management team's participation in several upcoming investor conferences. These include events hosted by H.C. Wainwright, Stifel, TD Cowen, and Jefferies from M…
Hawkins, Inc., a leading water treatment and specialty ingredients company, announced a quarterly cash dividend of $0.19 per share, payable on June 12, 2026, to shareholders of record as of May 29, 2026. The company has consistently paid dividends since 1985, reflecting financial stability and commitment to shareholder returns.
Lulu's Fashion Lounge Holdings, Inc. reported its Q1 2026 results demonstrating a $3.9 million improvement in net loss compared to Q1 2025, a 480 basis points increase in gross margin, and reduced total and net debt. Despite a 10% decrease in net revenue and lower active customers, the company achieved higher average order value and doubled wholesa…
Birchtech Corp. reported a 32% increase in first quarter 2026 revenues to $4.2 million driven by growth in water and air treatment segments. The company completed uplisting to the NYSE American along with a $16.4 million capital raise, launched the SEA-IX™ nuclear-grade ion exchange resin line with approximately $1 million in initial orders, and in…
Vivani Medical, a clinical-stage biopharmaceutical company, reported Q1 2026 financial results and business progress, highlighting the on-track initiation of the SLIM-1 Phase 1 clinical trial for its semaglutide implant in mid-2026. The company holds $28 million in cash and commitments, funding operations through H1 2027, and anticipates Phase 1 re…
Dyadic International, Inc. (NASDAQ: DYAI), a biotechnology firm specializing in animal-free recombinant proteins and enzymes, announced strong Q1 2026 financial results featuring a 182% increase in revenue compared to the previous year. Key advancements include commercial launches of products such as AlbuFree™ DX human albumin and recombinant DNase…
Bionano Genomics reported a 4% revenue increase to $6.7 million in Q1 2026, driven by a 20% rise in consumables revenue and a 17% increase in sold flow cells. Operating expenses slightly decreased and gross margin improved to 49%. The company benefits from new Category I CPT codes enhancing reimbursement for optical genome mapping (OGM) diagnostic …
AtlasClear Holdings, Inc. reported a 65% increase in Q3 2026 revenue to $4.2 million and a 67% increase year-to-date to $13.5 million, driven by expansion in securities lending and stock locate operations. The company significantly improved its balance sheet by reducing legacy de-SPAC liabilities by over 95%, flipping stockholders' equity from a de…
Fossil Group, Inc. reported net sales of $225 million for Q1 2026, a slight decrease due to shorter fiscal period and lower direct-to-consumer sales. Despite a 3.6% reported sales drop, the company achieved operating income of $12 million versus a loss last year, reflecting restructuring benefits and cost reductions. Gross margin declined slightly …
Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) reported its Q1 2026 financial results along with updates on the commercialization progress of GraftAssureDx, its kidney transplant monitoring assay. The company is advancing toward FDA marketing authorization expected later in 2026, with encouraging FDA dialogues. International research data valida…
Teekay Corporation Ltd. released its first quarter 2026 update and announced a special cash dividend of $1.00 per common share payable on June 2, 2026. The company operates in international crude oil marine transportation and related marine services with a fleet of mid-sized tankers and provides ship-to-ship transfer services.
Fluent, Inc. reported Q1 2026 financial results highlighting a strong performance in its Commerce Media Solutions segment, which grew 104% year-over-year to $25.9 million and now represents 58% of total revenue. Despite a 19% decline in total revenue due to divestiture of Call Solutions, Fluent expects full-year double-digit revenue growth driven b…
Eledon Pharmaceuticals announced first quarter 2026 financial results and recent business highlights, including significant clinical milestones for their lead drug candidate tegoprubart. Key achievements include 100% insulin independence in type 1 diabetes patients post-islet transplantation, FDA Orphan Drug designation for liver transplantation, a…
Teekay Tankers Ltd. announced its financial results for the first quarter ended March 31, 2026, and declared a fixed quarterly cash dividend of $0.25 per share alongside a special cash dividend of $1.00 per share, payable June 2, 2026. The company operates a fleet of 33 double-hull tankers and provides marine services, including ship-to-ship transf…
Brilliant Earth Group, Inc., a leader in ethically sourced fine jewelry, announced its participation in the B. Riley Securities Annual Investor Conference and the TD Cowen 10th Annual Future of the Consumer Conference. The company will engage with investors through meetings and a fireside chat webcast. With a mission focused on transparency and sus…
U.S. Global Investors reported net income of $2.7 million (EPS $0.23) for Q3 fiscal 2026, reversing prior losses. Operating revenues increased 10% sequentially and 31% year-over-year, driven by gains in gold and natural resources funds. Average assets under management reached $1.6 billion, the highest since mid-2024, bolstered by strong performance…
Snail, Inc., a Nasdaq-listed independent game developer and publisher, reported for Q1 2026 a 35.7% increase in net revenues to $27.3 million, a return to net income positive of $2.1 million, and strong operational performance with rising unit sales and daily active users of ARK franchise titles. The company outlined an extensive content pipeline i…
Robinhood Markets, Inc. reported robust operating data for April 2026, with funded customers reaching 27.6 million, total platform assets increasing 12% from March to $345 billion, and strong year-over-year growth in equities and options trading volumes. Despite a decline in crypto trading volumes from the prior month, overall trading activity and …
Seer, Inc. announced its first quarter 2026 financial results, reporting revenue of $2.8 million, down 34% year-over-year due to a depressed academic funding environment and increased competition. Despite the revenue drop, the company achieved key milestones including doubling independent publications, securing a major collaboration in Singapore, s…
Spero Therapeutics announced its financial results for Q1 2026 and provided a business update highlighting progress on its NDA for tebipenem HBr, an oral carbapenem antibiotic for complicated urinary tract infections, with an FDA PDUFA decision expected on June 18, 2026. The company reported a reduced net loss compared to last year, maintains a str…
Longeveron Inc. reported its Q1 2026 financial results highlighting ongoing development of laromestrocel, a proprietary stem cell therapy for serious conditions including Hypoplastic Left Heart Syndrome (HLHS) and Alzheimer's disease. The company raised $15 million in a private placement to fund current operations and expects topline data from a pi…
AppLovin (APP) tumbled intraday but the underlying business metrics - Q1 revenue growth north of 50%, stretched but improving margins, and a still-robust ad-monetization platform - argue for adding to longs here. This trade idea lays out a concrete entry at the current level, a defensive stop, and a target tied to prior highs with a long-term horiz…
Universal Display Corp (NASDAQ:OLED) saw recent insider activity from one of its directors, Richard C. Elias, who purchased common stock in May 2026. This transaction occurs against a backdrop of significant price fluctuations for the company's shares and recent quarterly financial results that failed to meet market expectations. While the company …
